BioSpace News Archive

Moderna, Inc. announced that it will host a Manufacturing & Digital Day for analysts and investors at 1:00 p.m. ET on Wednesday, March 4 at the Company’s manufacturing facility in Norwood, Massachusetts..

RECOVER sub-study will leverage Verily research tools to provide quantitative assessment measures of depressive episodes

Voyager Therapeutics, Inc., a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, will webcast management presentations as follows

Akorn, Inc., a leading specialty pharmaceutical company, announced its financial results for the quarter and year ended December 31, 2019.

The following quote is attributed to Frank Yiannas, Deputy Commissioner for Food Policy and Response

Antisense Therapeutics Limited is pleased to advise of the appointment of Gil Price M.D. as Consultant Medical Director..

Genomma Lab Internacional, S.A.B. de C.V., announced its results for the fourth quarter and the full year ended December 31, 2019.

Rapid Dx encourages all local communities globally to have their diagnostic clinics test immediately for COVID-19 to contain the spread into the general population.

Feb. 26, 2020 13:30 UTC –The cohort of Eversense ® CGM users will also test modified sensor chemistry.– GERMANTOWN, Md.--( BUSINESS WIRE )-- Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system – the Eversense ® CGM System – today announced the FDA approved a subgroup (with a modified chemistry to enhance longevi

Concord Technologies, a leading provider of cloud-based fax and intelligent document automation software for healthcare providers and enterprises in other regulated industries, announced today the appointment of Christopher Larkin as Chief Technology Officer (CTO)